Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol

INTRODUCTION: Prostate cancer is the most common male cancer with one in four developing non-curable metastatic disease. Initial treatment responses to hormonal therapies are transient and further management options lie between (1) further hormone therapy or (2) a non-hormonal approach involving add...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Emma, Morton, Miranda, Sharma, Shriya, Fisher, Holly, Howel, Denise, Walker, Jenn, Wood, Ruth, Hancock, Helen, Maier, Rebecca, Marshall, John, Bahl, Amit, Crabb, Simon, Jain, Suneil, Pedley, Ian, Jones, Rob, Staffurth, John, Heer, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937062/
https://www.ncbi.nlm.nih.gov/pubmed/31857319
http://dx.doi.org/10.1136/bmjopen-2019-034708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937062/
https://www.ncbi.nlm.nih.gov/pubmed/31857319
http://dx.doi.org/10.1136/bmjopen-2019-034708

Ejemplares similares